SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-20-271661
Filing Date
2020-10-19
Accepted
2020-10-19 07:33:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d82229dsc14d9.htm SC 14D9 635569
2 EX-99.(E)(15) d82229dex99e15.htm EX-99.(E)(15) 21456
3 EX-99.(E)(18) d82229dex99e18.htm EX-99.(E)(18) 30891
4 GRAPHIC g82229g16b05.jpg GRAPHIC 27084
5 GRAPHIC g82229g33b42.jpg GRAPHIC 3566
  Complete submission text file 0001193125-20-271661.txt   729008
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filed by) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Subject) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-89169 | Film No.: 201245236
SIC: 2834 Pharmaceutical Preparations